ASND · Healthcare · $14.2B
$227.31-0.23%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
Preliminary · some items pending
3/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“2분기 매출은 3억3,900만 유로로 직전 분기 약 3,900만 달러 수준에서 급증했지만, 특허권 우선심사권 매각 수익과 YORVIPATH 매출”
In the company's words · 2026 2분기 earnings call